NCT00368238View on ClinicalTrials.gov

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

July 31, 2006

Conditions
Healthy Subjects
Interventions
DRUG

Recombinant human erythropoietin alfa (drug)

DRUG

Aspirin (drug)

DRUG

Clopidogrel (drug)

Trial Locations (1)

06510

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Yale University

OTHER

NCT00368238 - Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects | Biotech Hunter | Biotech Hunter